Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 618 items.
Health Canada is advising about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as "…
AlertPublic advisory | 2022-08-15
Taro Pharmaceuticals Inc. is recalling all lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because they may contain particulate matter.
Zoledronic acid is a prescription drug used to treat and prevent osteoporosis and to treat Paget's…
RecallHealth product recall | 2022-08-10
Taro Pharmaceuticals Inc. is recalling all lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because they may contain particulate matter.
Zoledronic acid is a prescription drug used to treat and prevent osteoporosis and to treat Paget's…
AlertPublic advisory | 2022-08-09
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.…
RecallHealth product recall | 2022-08-08
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.
Atorvastatin is a…
AlertPublic advisory | 2022-08-06
Solution bags may be leaking in affected lot.
RecallHealth product recall | 2022-08-04
The affected lots may contain glass particles.
RecallHealth product recall | 2022-08-02
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2022-07-28
Potency out of specification results in the affected lots
RecallHealth product recall | 2022-07-28
UPDATE (July 28, 2022): Update: Apotex recalls additional Apo-Acyclovir tablets due to a nitrosamine impurity
Apotex Inc. is recalling four additional lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a…
AlertPublic advisory | 2022-07-28
As part of Operation Pangea XV — an international effort to disrupt the online sale of counterfeit and other illegal health products around the world—Health Canada is reminding consumers to be careful when buying health products over the Internet. Health…
AlertPublic advisory | 2022-07-20
Affected cylinders may not be filled with adequate amount of product.
RecallHealth product recall | 2022-07-13
The affected lots may contain an undeclared ingredient, bimatoprost, listed on the prescription drug list.
RecallHealth product recall | 2022-07-11
The sterility is out of specification in the affected lot (Periodic Media Fill Validation failure).
RecallHealth product recall | 2022-06-30
Product sold without market authorization. Affected lots are labelled with unauthorized claims.
RecallHealth product recall | 2022-06-30